|
1
|
Almeida de Oliveira LS, de Moura Bandeira SR, Gomes Gonçalves RL, Pereira de Sousa Neto B, Carvalho de Rezende D, dos Reis-Filho AC, Sousa IJO, Pinheiro-Neto FR, Timah Acha B, do Nascimento Caldas Trindade G, do Nascimento LG, de Sousa DP, de Castro Almeida FR, Lucarini M, Durazzo A, Arcanjo DDR, de Assis Oliveira F. The Isopropyl Gallate Counteracts Cyclophosphamide-Induced Hemorrhagic Cystitis in Mice. BIOLOGY 2022; 11:728. [PMID: 35625456 PMCID: PMC9138278 DOI: 10.3390/biology11050728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/22/2022] [Revised: 05/07/2022] [Accepted: 05/08/2022] [Indexed: 01/08/2023]
Abstract
Hemorrhagic cystitis is the main adverse effect associated with the clinical use of oxazaphosphorine, resulting in increased oxidative stress and proinflammatory cytokines, which culminate in injury of the bladder tissue. The aim of this study was to evaluate the protective effect of isopropyl gallate (IPG) against ifosfamide (IFOS)-induced hemorrhagic cystitis in mice. The induction of the hemorrhagic cystitis model was carried out using a single dose of IFOS (400 mg/kg, i.p.) four hours after oral pretreatment with IPG (6.25, 12.5, 25, and 50 mg/kg) or saline (vehicle). Mesna (positive control; 80 mg/kg, i.p.) was administered four hours before and eight hours after induction of cystitis. In the present study, IPG 25 mg/kg significantly decreased edema and hemorrhage, with a reduction of the bladder wet weight (36.86%), hemoglobin content (54.55%), and peritoneal vascular permeability (42.94%) in urinary bladders of mice. Interestingly, IPG increased SOD activity (89.27%) and reduced MDA levels (35.53%), as well as displayed anti-inflammatory activity by decreasing TNF-α (88.77%), IL-1β (62.87%), and C-reactive protein (56.41%) levels. Our findings demonstrate that IPG has a substantial protective role against IFOS-induced hemorrhagic cystitis in mice by enhancing antioxidant activity and proinflammatory mechanisms. Thus, IPG represents a promising co-adjuvant agent in oxazaphosphorine-based chemotherapy treatments.
Collapse
Affiliation(s)
- Lucas Solyano Almeida de Oliveira
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Sara Raquel de Moura Bandeira
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Rodrigo Lopes Gomes Gonçalves
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Benedito Pereira de Sousa Neto
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Diana Carvalho de Rezende
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Antonio Carlos dos Reis-Filho
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Ian Jhemes Oliveira Sousa
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Flaviano Ribeiro Pinheiro-Neto
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Boris Timah Acha
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Gabriela do Nascimento Caldas Trindade
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Lázaro Gomes do Nascimento
- Laboratory of Pharmaceutical Chemistry, Federal University of Paraíba, João Pessoa 58051-900, Brazil; (L.G.d.N.); (D.P.d.S.)
| | - Damião Pergentino de Sousa
- Laboratory of Pharmaceutical Chemistry, Federal University of Paraíba, João Pessoa 58051-900, Brazil; (L.G.d.N.); (D.P.d.S.)
| | - Fernanda Regina de Castro Almeida
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| | - Massimo Lucarini
- CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy; (M.L.); (A.D.)
| | - Alessandra Durazzo
- CREA-Research Centre for Food and Nutrition, Via Ardeatina 546, 00178 Rome, Italy; (M.L.); (A.D.)
| | - Daniel Dias Rufino Arcanjo
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
- Laboratory of Functional and Molecular Studies in Physiopharmacology, Department of Biophysics and Physiology, Federal University of Piauí, Teresina 64049-550, Brazil
| | - Francisco de Assis Oliveira
- Medicinal Plants Research Center, Federal University of Piauí, Av. Nossa Senhora de Fátima s/n, Teresina 64049-550, Brazil; (L.S.A.d.O.); (S.R.d.M.B.); (R.L.G.G.); (B.P.d.S.N.); (D.C.d.R.); (A.C.d.R.-F.); (I.J.O.S.); (F.R.P.-N.); (B.T.A.); (G.d.N.C.T.); (F.R.d.C.A.); (F.d.A.O.)
| |
Collapse
|
|
2
|
Pinzón Mariño S, Bakali Badesa S, Viso Soriano MJ, Izquierdo Garcia I. Hemorrhagic cystitis: A successful outcome for a challenging complication in stem cell transplant. Hematol Rep 2021; 13:8574. [PMID: 33747409 PMCID: PMC7970400 DOI: 10.4081/hr.2021.8574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2020] [Accepted: 10/15/2020] [Indexed: 11/23/2022] Open
Abstract
Hemorrhagic cystitis (HC) secondary to BK polyomavirus (BKPyV) is a frequent complication related to allogenic stem cell transplantation. With an important morbidity and mortality, this disease doesn’t have a stablished standard treatment or prophylaxis strategies. At this moment, the supportive therapies approved to treat included hyperhydration, forced diuresis and transfusion support. Cidofovir is a nucleotide analog of deoxycytidine monophosphate against DNA viruses and it has been described for the treatment of BKPyV-HC, but at this moment, is not a front-line therapy. We report a successful case after the use of Cidofovir without Probenecid. No adverse effect was developed under the treatment, and after 4 weeks of treatment, the patient achieved an excellent response.
Collapse
|
|
3
|
Ferrer A, Viña MM, Limiñana EP, Merino J. Intravesical cidofovir, use in BK polyomavirus-associated haemorrhagic cystitis after haematopoietic stem cell transplantation: off-label. Nefrologia 2021; 41:79-80. [PMID: 36165369 DOI: 10.1016/j.nefroe.2020.02.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Accepted: 02/25/2020] [Indexed: 06/16/2023] Open
Affiliation(s)
- Alejandro Ferrer
- Servicio de Farmacia Hospitalaria, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
| | - María Micaela Viña
- Servicio de Farmacia Hospitalaria, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
| | - Elisa Pérez Limiñana
- Servicio de Enfermería, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
| | - Javier Merino
- Servicio de Farmacia Hospitalaria, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain
| |
Collapse
|
|
4
|
Ferrer Machín A, Viña Romero MM, Limiñana EP, Merino Alonso J. Cidofovir intravesical, use in BK poliomavirus associated haemorrhagic cystitis after a transplantation of hematopoyetic progenitors: Off-label. Nefrologia 2020; 41:79-80. [PMID: 32513510 DOI: 10.1016/j.nefro.2020.02.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Revised: 02/15/2020] [Accepted: 02/25/2020] [Indexed: 11/30/2022] Open
Affiliation(s)
- Alejandro Ferrer Machín
- Servicio de Farmacia Hospitalaria, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Tenerife, España.
| | - María Micaela Viña Romero
- Servicio de Farmacia Hospitalaria, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Tenerife, España
| | - Elisa Pérez Limiñana
- Servicio de Enfermería, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Tenerife, España
| | - Javier Merino Alonso
- Servicio de Farmacia Hospitalaria, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Tenerife, España
| |
Collapse
|